Keiji AI LogoKeiji AI
Research & Innovation

Research behind TrialMind

Peer-reviewed methods organized around the six teams TrialMind serves, from trial design and real-world evidence to clinical operations, portfolio decisions, HTA, and investigator-led research.

Research by workflow

Six research areas. The same six doors into the product.

Drug-discovery and multimodal research remains part of the scientific foundation. Evidence-based medicine is split into the specific RWE, intelligence, and HEOR decisions it supports.

For biometrics and quantitative science teams

Biostatistics & Trial Design

Methods for designing more feasible trials, simulating outcomes, and creating analysis-ready evidence for statistical teams.

Trial design and simulation
Statistical programming
Digital twins and synthetic controls
See the solution use cases

For strategy, search, and portfolio teams

Competitive & Portfolio Intelligence

Clinical-trial foundation models and predictive methods for landscape analysis, probability of success, and evidence-backed portfolio decisions.

Trial landscape and KOL discovery
Probability of technical success
Portfolio and indication assessment
See the solution use cases

For clinical development and trial operations teams

Clinical Development & Operations

Research that improves site selection, patient-trial matching, recruitment, and the operational decisions that determine whether a trial finishes.

Evidence-based site selection
Patient matching and recruitment
Enrollment and dropout prediction
See the solution use cases

For evidence synthesis, value, and access teams

HEOR & Market Access

Human-AI evidence synthesis methods for systematic reviews, reproducible screening, and evidence bases that can stand up to HTA scrutiny.

Systematic literature review
PRISMA screening and extraction
Reusable HTA evidence bases
See the solution use cases

For investigators, departments, and research informatics

Research Institutions

Foundational AI, including drug-discovery and multimodal methods, plus data-science agents that help investigators run reproducible biomedical studies.

Investigator-led data science
Multimodal biomedical research
Reproducible methods and training
See the solution use cases

From research to product

Publication is the start of the evidence chain

The workflow defines the research question

We start from the decision a biometrics, RWE, operations, intelligence, HEOR, or academic team has to make.

Methods are measured, not merely demonstrated

Peer review, purpose-built benchmarks, and comparisons against established baselines make performance inspectable.

Evidence remains traceable

Sources, assumptions, and intermediate decisions stay connected to the final output so teams can review and reproduce the work.

Explore the evidence

Read the papers, then see where the methods are used.

The publication archive contains every paper under its primary ICP category, with keyword filtering for methods that cross workflows.

Trusted Partners

Trusted by Leading Organizations

From top pharma companies to academic medical centers

AbbVie logo
Regeneron logo
Takeda logo
Guardant Health logo
Beth Israel Deaconess Medical Center logo
Alumis logo
AbbVie logo
Regeneron logo
Takeda logo
Guardant Health logo
Beth Israel Deaconess Medical Center logo
Alumis logo